RxSight (NASDAQ:RXST) Price Target Cut to $28.00 by Analysts at Stifel Nicolaus
RxSight (NASDAQ:RXST – Get Free Report) had its target price cut by equities researchers at Stifel Nicolaus from $33.00 to $28.00 in a research note issued to investors on Wednesday,Benzinga reports. The firm presently has a “hold” rating on the stock. Stifel Nicolaus’ price objective indicates a potential upside of 12.45% from the stock’s previous […]
